Month: March 2021

Mar 04 2021

Uncategorized

Seeing schizophrenia: X-rays shed light on neural differences, point toward treatment

by Clinical Editor

No Comments

Schizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person’s thoughts, feelings and behavior. Symptoms include delusions, …

Mar 04 2021

Uncategorized

Psychedelics And Schizophrenia: What’s The Link?

by Clinical Editor

No Comments

Psychedelics and schizophrenia share a history. Now, researchers are looking at how psychedelics may change the future. Can psychedelics help treat schizophrenia? LSD-25 sat on a shelf for five years...

Mar 04 2021

Uncategorized

‘Landmark’ Schizophrenia Drug in the Wings?

by Clinical Editor

No Comments

A novel treatment that combines a muscarinic receptor agonist with an anticholinergic agent is associated with greater reduction in psychosis vs placebo, new research shows.

Mar 03 2021

Uncategorized

‘Landmark’ Schizophrenia Drug in the Wings? – Medscape

by Clinical Editor

No Comments

‘Landmark’ Schizophrenia Drug in the Wings?  Medscape

Mar 03 2021

Uncategorized

A closely watched schizophrenia drug fails key test – BioPharma Dive

by Clinical Editor

No Comments

A closely watched schizophrenia drug fails key test  BioPharma Dive

Mar 03 2021

Uncategorized

Neurocrine Biosciences Announces Top-Line Results from Phase II INTERACT Study Evaluating Luvadaxistat (NBI-1065844) for the Treatment of Negative Symptoms and Cognitive Impairment Associated with Schizophrenia (CIAS) – PRNewswire

by Clinical Editor

No Comments

Neurocrine Biosciences Announces Top-Line Results from Phase II INTERACT Study Evaluating Luvadaxistat (NBI-1065844) for the Treatment of Negative Symptoms and Cognitive Impairment Associated with Schizophrenia (CIAS)  PRNewswire

Mar 03 2021

Uncategorized

Functional connectivity abnormalities of the long-axis hippocampal subregions in schizophrenia during episodic memory

by Clinical Editor

No Comments

Past evidence suggests that hippocampal subregions, namely the anterior and posterior parts, may be engaged in distinct networks underlying the memory functions which may be altered in patients with …

Mar 03 2021

Uncategorized

Seeing schizophrenia: X-rays shed light on neural differences, point toward treatment

by Clinical Editor

No Comments

Schizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person’s thoughts, feelings and behavior. Symptoms include delusions, …

Mar 03 2021

Uncategorized

Reduced cortical gyrification in the posteromedial cortex in unaffected relatives of schizophrenia patients with high genetic loading

by Clinical Editor

No Comments

Although abnormal cortical gyrification has been consistently reported in patients with schizophrenia, whether gyrification abnormalities reflect a genetic risk for the disorder remains unknown. This …

Mar 03 2021

Uncategorized

Psychedelics And Schizophrenia: What’s The Link?

by Clinical Editor

No Comments

Psychedelics and schizophrenia share a history. Now, researchers are looking at how psychedelics may change the future. Can psychedelics help treat schizophrenia? LSD-25 sat on a shelf for five years...